MTOR and glioblastoma: Given the importance of mTOR signaling in cell growth, proliferation, metabolism, and survival, this pathway is a potential therapeutic target, and our data support ongoing exploration of mTOR pathway inhibition as combination therapy for patients with GBM (48).